Shenzhen Chipscreen Biosciences Balance Sheet Health
Financial Health criteria checks 2/6
Shenzhen Chipscreen Biosciences has a total shareholder equity of CN¥1.7B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 66%. Its total assets and total liabilities are CN¥3.2B and CN¥1.5B respectively.
Key information
66.0%
Debt to equity ratio
CN¥1.12b
Debt
Interest coverage ratio | n/a |
Cash | CN¥620.15m |
Equity | CN¥1.69b |
Total liabilities | CN¥1.52b |
Total assets | CN¥3.21b |
Recent financial health updates
No updates
Recent updates
Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%
Apr 24Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)
Apr 05Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up
Mar 06Financial Position Analysis
Short Term Liabilities: 688321's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥352.4M).
Long Term Liabilities: 688321's short term assets (CN¥1.1B) do not cover its long term liabilities (CN¥1.2B).
Debt to Equity History and Analysis
Debt Level: 688321's net debt to equity ratio (29.3%) is considered satisfactory.
Reducing Debt: 688321's debt to equity ratio has increased from 31.8% to 66% over the past 5 years.
Debt Coverage: 688321's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 688321's interest payments on its debt are well covered by EBIT.